Alnylam Pharmaceuticals

ALNYNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$32.692 B

$244.32 +1.99%

Close of 21 Sept 2026

Revenue

$3.71B

#817 by revenue

Earnings

$313.7M

#819 by earnings

Shares outstanding

133,809,118

Latest filing cover page

P/E ratio

104.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#17BeOne MedicinesONC$41.6B
#18Royalty PharmaRPRX$33.6B
#19Alnylam PharmaceuticalsALNY$32.7B
#20ZoetisZTS$29.5B
#21Roivant SciencesROIV$28.2B

What if Alnylam Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$226,248.07

Per share 926× higher

Bitcoin $1.72T

$12,852.66

Per share 52.6× higher

Nvidia $5.48T

$40,952.80

Per share 168× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for Alnylam Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.